In the last 12 months, insiders at COGNITION THERAPEUTICS INC ($CGTX) filed 63 transactions with the SEC: 2 open-market purchases totaling $39,976 and 0 sales totaling $0. Net insider sentiment: net buying.
COGNITION THERAPEUTICS INC operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Ricciardi Lisa (CEO & President) — 16 transactions totaling $266,645
- Caggiano Anthony (Chief Medical Officer) — 14 transactions totaling $130,742
- Doyle John Brendan (Chief Financial Officer) — 13 transactions totaling $72,103
- Fletcher Aaron G.L. (Director) — 5 transactions totaling $6,492
- RICHSTONE ELLEN B (Director) — 3 transactions totaling $0
View all SEC Filings for COGNITION THERAPEUTICS INC (CGTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 1560 | $1.12 | 617,509.0000 | 77,951,513 | 0.25% | 0.00% |
| Feb. 15, 2026 | Ricciardi Lisa | CEO & President | F | Common Stock | 5850 | $1.12 | 1,745,527.0000 | 77,951,513 | 0.33% | 0.01% |
| Feb. 15, 2026 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 4680 | $1.12 | 864,906.0000 | 77,951,513 | 0.54% | 0.01% |
| Feb. 3, 2026 | Ricciardi Lisa | CEO & President | F | Common Stock | 26036 | $1.12 | 1,803,081.0000 | 77,951,513 | 1.42% | 0.03% |
| Feb. 4, 2026 | Ricciardi Lisa | CEO & President | F | Common Stock | 51704 | $1.03 | 1,751,377.0000 | 77,951,513 | 2.87% | 0.07% |
| Feb. 3, 2026 | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 200000 | $0.00 | 645,990.0000 | 77,951,513 | 44.84% | 0.26% |
| Feb. 4, 2026 | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 26921 | $1.03 | 619,069.0000 | 77,951,513 | 4.17% | 0.03% |
| Feb. 3, 2026 | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 400000 | $0.00 | 907,993.0000 | 77,951,513 | 78.74% | 0.51% |
| Feb. 3, 2026 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 11488 | $1.12 | 896,505.0000 | 77,951,513 | 1.27% | 0.01% |
| Feb. 4, 2026 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 26919 | $1.03 | 869,586.0000 | 77,951,513 | 3.00% | 0.03% |
| Feb. 3, 2026 | Ricciardi Lisa | CEO & President | A | Common Stock | 800000 | $0.00 | 1,829,117.0000 | 77,951,513 | 77.74% | 1.03% |
| Dec. 18, 2025 | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 65000 | $0.00 | 528,273.0000 | 77,951,513 | 14.03% | 0.08% |
| Dec. 18, 2025 | Ricciardi Lisa | CEO & President | A | Common Stock | 75000 | $0.00 | 1,052,517.0000 | 77,951,513 | 7.67% | 0.10% |
| Dec. 18, 2025 | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 9360 | $1.50 | 445,990.0000 | 77,951,513 | 2.06% | 0.01% |
| Dec. 18, 2025 | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 455,350.0000 | 77,951,513 | 7.05% | 0.04% |
| Dec. 18, 2025 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 20280 | $1.50 | 507,993.0000 | 77,951,513 | 3.84% | 0.03% |
| Dec. 18, 2025 | Ricciardi Lisa | CEO & President | F | Common Stock | 23400 | $1.50 | 1,029,117.0000 | 77,951,513 | 2.22% | 0.03% |
| Sept. 19, 2025 | Fletcher Aaron G.L. | Director | M | Common Stock | 7729 | $0.84 | 6,056,229.0000 | 63,690,945 | 0.13% | 0.01% |
| Sept. 19, 2025 | Fletcher Aaron G.L. | Director | M | Stock Option (right to buy) | 7729 | $0.00 | 0.0000 | 63,690,945 | 100.00% | 0.01% |
| July 29, 2025 | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 9360 | $0.67 | 425,350.0000 | 63,690,945 | 2.15% | 0.01% |
| July 29, 2025 | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 434,710.0000 | 63,690,945 | 7.41% | 0.05% |
| July 29, 2025 | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 65000 | $0.00 | 483,554.0000 | 63,690,945 | 15.53% | 0.10% |
| July 29, 2025 | Ricciardi Lisa | CEO & President | F | Common Stock | 23400 | $0.67 | 977,517.0000 | 63,690,945 | 2.34% | 0.04% |
| July 29, 2025 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 20281 | $0.67 | 463,273.0000 | 63,690,945 | 4.19% | 0.03% |
| July 29, 2025 | Ricciardi Lisa | CEO & President | A | Common Stock | 75000 | $0.00 | 1,000,917.0000 | 63,690,945 | 8.10% | 0.12% |
| June 18, 2025 | Wallace Peggy | Director | A | Common Stock | 34000 | $0.00 | 86,461.0000 | 61,828,149 | 64.81% | 0.05% |
| June 18, 2025 | Khattar Jack A. | Director | A | Common Stock | 34000 | $0.00 | 48,500.0000 | 61,828,149 | 234.48% | 0.05% |
| June 18, 2025 | RICHSTONE ELLEN B | Director | A | Common Stock | 34000 | $0.00 | 58,500.0000 | 61,828,149 | 138.78% | 0.05% |
| June 18, 2025 | Monia Brett P | Director | A | Common Stock | 34000 | $0.00 | 48,500.0000 | 61,828,149 | 234.48% | 0.05% |
| June 18, 2025 | Kreis Leslie W. | Director | A | Common Stock | 34000 | $0.00 | 6,048,500.0000 | 61,828,149 | 0.57% | 0.05% |
| June 18, 2025 | Fletcher Aaron G.L. | Director | A | Common Stock | 34000 | $0.00 | 6,048,500.0000 | 61,828,149 | 0.57% | 0.05% |
| May 1, 2025 | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 9692 | $0.45 | 404,710.0000 | 61,828,149 | 2.34% | 0.02% |
| Feb. 15, 2025 | Ricciardi Lisa | CEO & President | F | Common Stock | 6619 | $0.59 | 887,066.0000 | 39,730,148 | 0.74% | 0.02% |
| Feb. 15, 2025 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 5296 | $0.59 | 418,554.0000 | 39,730,148 | 1.25% | 0.01% |
| Feb. 15, 2025 | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 1723 | $0.59 | 414,402.0000 | 39,730,148 | 0.41% | 0.00% |
| Feb. 3, 2025 | Ricciardi Lisa | CEO & President | F | Common Stock | 28960 | $0.67 | 301,236.0000 | 39,730,148 | 8.77% | 0.07% |
| Feb. 4, 2025 | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 295000 | $0.00 | 416,125.0000 | 39,730,148 | 243.55% | 0.74% |
| Jan. 31, 2025 | Ricciardi Lisa | CEO & President | P | Common Stock | 38851 | $0.77 | 932,536.0000 | 39,730,148 | 4.35% | 0.10% |
| Feb. 3, 2025 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 12779 | $0.67 | 128,850.0000 | 39,730,148 | 9.02% | 0.03% |
| Feb. 4, 2025 | Ricciardi Lisa | CEO & President | A | Common Stock | 631300 | $0.00 | 932,536.0000 | 39,730,148 | 209.57% | 1.59% |
| Feb. 4, 2025 | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 295000 | $0.00 | 423,850.0000 | 39,730,148 | 228.95% | 0.74% |
| June 7, 2024 | Wallace Peggy | Director | A | Common Stock | 8500 | $0.00 | 52,461.0000 | 33,735,269 | 19.34% | 0.03% |
| June 7, 2024 | RICHSTONE ELLEN B | Director | A | Common Stock | 8500 | $0.00 | 24,500.0000 | 33,735,269 | 53.13% | 0.03% |
| June 7, 2024 | RICHSTONE ELLEN B | Director | A | Stock Option (right to buy) | 8500 | $0.00 | 8,500.0000 | 33,735,269 | 9999.99% | 0.03% |
| June 7, 2024 | Monia Brett P | Director | A | Common Stock | 8500 | $0.00 | 14,500.0000 | 33,735,269 | 141.67% | 0.03% |
| June 7, 2024 | Monia Brett P | Director | A | Stock Option (right to buy) | 8500 | $0.00 | 8,500.0000 | 33,735,269 | 9999.99% | 0.03% |
| June 7, 2024 | Khattar Jack A. | Director | A | Common Stock | 8500 | $0.00 | 14,500.0000 | 33,735,269 | 141.67% | 0.03% |
| June 7, 2024 | Wallace Peggy | Director | A | Stock Option (right to buy) | 8500 | $0.00 | 8,500.0000 | 33,735,269 | 9999.99% | 0.03% |
| June 7, 2024 | Khattar Jack A. | Director | A | Stock Option (right to buy) | 8500 | $0.00 | 8,500.0000 | 33,735,269 | 9999.99% | 0.03% |
| June 7, 2024 | Fletcher Aaron G.L. | Director | A | Stock Option (right to buy) | 8500 | $0.00 | 8,500.0000 | 33,735,269 | 9999.99% | 0.03% |
| June 7, 2024 | Fletcher Aaron G.L. | Director | A | Common Stock | 8500 | $0.00 | 6,014,500.0000 | 33,735,269 | 0.14% | 0.03% |
| June 7, 2024 | Kreis Leslie W. | Director | A | Stock Option (right to buy) | 8500 | $0.00 | 8,500.0000 | 33,735,269 | 9999.99% | 0.03% |
| June 7, 2024 | Kreis Leslie W. | Director | A | Common Stock | 8500 | $0.00 | 6,014,500.0000 | 33,735,269 | 0.14% | 0.03% |
| May 1, 2024 | Doyle John Brendan | Chief Financial Officer | F | Common Stock | 8699 | $1.95 | 121,125.0000 | 33,735,269 | 6.70% | 0.03% |
| March 14, 2024 | Ricciardi Lisa | CEO & President | P | Common Stock | 5700 | $1.75 | 291,345.0000 | 30,029,087 | 2.00% | 0.02% |
| Feb. 15, 2024 | Ricciardi Lisa | CEO & President | A | Common Stock | 75000 | $0.00 | 285,645.0000 | 30,029,087 | 35.60% | 0.25% |
| Feb. 15, 2024 | Caggiano Anthony | Chief Medical Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 30,029,087 | 9999.99% | 0.20% |
| Feb. 15, 2024 | Doyle John Brendan | Chief Financial Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 30,029,087 | 9999.99% | 0.07% |
| Feb. 15, 2024 | Doyle John Brendan | Chief Financial Officer | A | Common Stock | 20000 | $0.00 | 129,824.0000 | 30,029,087 | 18.21% | 0.07% |
| Feb. 15, 2024 | Caggiano Anthony | Chief Medical Officer | A | Common Stock | 60000 | $0.00 | 141,629.0000 | 30,029,087 | 73.50% | 0.20% |
| Feb. 15, 2024 | Ricciardi Lisa | CEO & President | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 30,029,087 | 9999.99% | 0.25% |
| Feb. 3, 2024 | Ricciardi Lisa | CEO & President | F | Common Stock | 27828 | $2.29 | 210,645.0000 | 30,029,087 | 11.67% | 0.09% |
| Feb. 3, 2024 | Caggiano Anthony | Chief Medical Officer | F | Common Stock | 12777 | $2.29 | 81,629.0000 | 30,029,087 | 13.53% | 0.04% |